"
Fasting for Laboratory Tests Poses a High Risk of Hypoglycemia in Patients with Diabetes: A Pilot Prevalence Study in Clinical Practice"
written by Saleh Aldasouqi, William Corser, George S. Abela, Samia Mora, Keren Shahar, Preethi Krishnan, Farhan Bhatti, Andrew Hsu, Dane Gruenebaum,
published by
International Journal of Clinical Medicine,
Vol.7 No.10, 2016
has been cited by the following article(s):
[1]
|
Assessing the dyslipidemias: to fast or not to fast?
Current Opinion in Endocrinology, Diabetes & Obesity,
2021
DOI:10.1097/MED.0000000000000615
|
|
|
[2]
|
Assessing the dyslipidemias: to fast or not to fast?
Current Opinion in Endocrinology, Diabetes & Obesity,
2021
DOI:10.1097/MED.0000000000000615
|
|
|
[3]
|
Fasting-Evoked En Route Hypoglycemia in Diabetes (FEEHD): From Guidelines to Clinical Practice
Current Diabetes Reviews,
2020
DOI:10.2174/1573399816666200107103829
|
|
|
[4]
|
Patient Preparation for Outpatient Blood Work and the Impact of Surreptitious Fasting on Diagnoses of Diabetes and Prediabetes
Mayo Clinic Proceedings: Innovations, Quality & Outcomes,
2020
DOI:10.1016/j.mayocpiqo.2020.04.002
|
|
|
[5]
|
Association of Nonfasting vs Fasting Lipid Levels With Risk of Major Coronary Events in the Anglo-Scandinavian Cardiac Outcomes Trial–Lipid Lowering Arm
JAMA Internal Medicine,
2019
DOI:10.1001/jamainternmed.2019.0392
|
|
|
[6]
|
Fasting-Evoked En Route Hypoglycemia in Diabetes (FEEHD): An Overlooked Form of Hypoglycemia in Clinical Practice
International Journal of Endocrinology,
2018
DOI:10.1155/2018/1528437
|
|
|